Search results
Results from the WOW.Com Content Network
The price of a new drug (in most cases) is limited so that the cost of therapy with the new drug is in the range of the costs of therapy with existing drugs in the same therapeutic class. The price of a breakthrough drug is limited to the median of its prices in France, Germany, Italy, Sweden, Switzerland, Britain, and the United States.
Hikma's branded business segment comprises the development and sales of branded generics and in-licensed patented products in the MENA region.Hikma has 499 products in 1,256 dosage strengths.
A pill was originally defined as a small, round, solid pharmaceutical oral dosage form of medication. The word's etymology reflects the historical concepts of grinding the ingredients with a mortar and pestle and rolling the resultant paste or dough into lumps to be dried.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx. FDA approves first new type of ...
G.D. Searle, LLC is a wholly owned subsidiary of Pfizer. [1] It is currently a trademark company and subsidiary of Pfizer, operating in more than 43 countries. It also operates as a distribution trademark for various pharmaceuticals that were developed by G. D. Searle & Company (often referred to as Searle).
Cost Plus Drugs was launched in January 2022. [3] It was co-founded by radiologist Alex Oshmyansky and billionaire Mark Cuban.According to Cuban, in 2018, Oshmyansky contacted Cuban with an email titled "cold pitch" in which he asked Cuban to invest in a pharmacy he envisioned to manufacture generic drugs and skip the middleman wholesalers. [4]
Maalox was developed in collaboration between William H. Rorer, Inc. and a medical doctor and researcher specializing in gastrointestinal issues, Alison Howe Price from Philadelphia. [3] The collaboration came about after World War II when Claude Newhart, a salesman and pharmacist for the company had an idea that he thought might change the ...
Zantac was first marketed in 1981, [7] and it was described in 1989 as "one of the most expensive drugs on the market", [8] and "the world's biggest-selling prescription drug". [9]